NMPA
The National Medical Products Administration of China, responsible for the approval and regulation of medical devices and pharmaceuticals.
Timeline (last 90 days)
GxP is the collective term for the Good Practice series of regulations, covering GMP, GCP, GLP, and others, enforced by national drug regulatory agencies (such as the U.S. FDA and China's NMPA).
Medical-grade exoskeleton devices used for rehabilitation training or mobility assistance are classified as medical devices in most markets and require approval by drug regulatory authorities; in China they are Class II or Class III medical devices under NMPA, in the United States they follow the FDA's 510(k) or De Novo pathway, and the clinical validation cycle typically takes years.
Regulatory agencies (such as the FDA and NMPA) are increasingly inclined to require prospective evidence when approving clinical AI products.
CT scanners are high-risk medical devices subject to strict regulation by agencies such as the FDA and NMPA.
All Facts (4)
GxP is the collective term for the Good Practice series of regulations, covering GMP, GCP, GLP, and others, enforced by national drug regulatory agencies (such as the U.S. FDA and China's NMPA).
50%UnverifiedMedical-grade exoskeleton devices used for rehabilitation training or mobility assistance are classified as medical devices in most markets and require approval by drug regulatory authorities; in China they are Class II or Class III medical devices under NMPA, in the United States they follow the FDA's 510(k) or De Novo pathway, and the clinical validation cycle typically takes years.
50%UnverifiedRegulatory agencies (such as the FDA and NMPA) are increasingly inclined to require prospective evidence when approving clinical AI products.
50%UnverifiedCT scanners are high-risk medical devices subject to strict regulation by agencies such as the FDA and NMPA.
50%